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We recently identified human N-acetyltransferase 2
(NAT2) as an insulin resistance (IR) gene. Here, we
examine the cellular mechanism linking NAT2 to IR
and find that Nat1 (mouse ortholog of NAT2) is
co-regulated with key mitochondrial genes. RNAi-
mediated silencing of Nat1 led to mitochondrial
dysfunction characterized by increased intracellular
reactive oxygen species and mitochondrial fragmen-
tation as well as decreasedmitochondrial membrane
potential, biogenesis, mass, cellular respiration, and
ATP generation. These effects were consistent in
3T3-L1 adipocytes, C2C12 myoblasts, and in tissues
from Nat1-deficient mice, including white adipose
tissue, heart, and skeletal muscle. Nat1-deficient
mice had changes in plasma metabolites and lipids
consistent with a decreased ability to utilize fats
for energy and a decrease in basal metabolic rate
and exercise capacity without altered thermogene-
sis. Collectively, our results suggest that Nat1 defi-
ciency results in mitochondrial dysfunction, which
may constitute a mechanistic link between this
gene and IR.
INTRODUCTION
The worldwide prevalence of insulin resistance (IR) and its
metabolic complications have increased substantially in recent
decades (Facchini et al., 2001; Frayn, 2001; Reaven, 1988; Yip
et al., 1998). It is estimated that 25% to 33% of the USA popula-
tion is sufficiently insulin resistant to be at risk for adverse clinical
consequences. At a tissue level, while decreased insulin-medi-
ated glucose uptake in skeletal muscle is a cardinal feature of
IR, it is also apparent that IR and dysfunctional adipose tissue
are inextricably intertwined and co-occur in type 2 diabetes mel-
litus (T2D) and cardiovascular disease (Kim et al., 2007; Wang
et al., 2005; Weyer et al., 2000). Hallmarks of IR in adipose tissueC
This is an open access article under the CC BY-Ninclude decreased insulin-mediated glucose uptake, inability of
insulin to suppress lipolysis, dysregulation of adipocyte growth
and differentiation, mitochondrial dysfunction, disrupted adipo-
kine signaling, and, in some instances, increased inflammation
(De Pauw et al., 2009). Nevertheless, the genetic and cellular
mechanisms underlying IR in adipose tissue remain incompletely
understood.
We recently identified an association of non-synonymous cod-
ing SNPs in the humanN-acetyltransferase 2 (NAT2) genewith IR
using a genome-wide association study (GWAS) approach, and
we validated these findings in vitro and in vivo through perturba-
tions of themurine orthologNat1. In themurine 3T3-L1 adipocyte
cell line, silencing Nat1 decreased insulin-mediated glucose up-
take and increased basal and isoproterenol-stimulated lipolysis.
Nat1-deficient mice had elevated fasting blood glucose, insulin,
and triglyceride levels and decreased insulin sensitivity, as
measured by glucose and insulin tolerance tests (Knowles
et al., 2015). The exact mechanism linking the association of
Nat1 with IR remains unclear, and identification of the missing
link among Nat1, insulin action, and cellular metabolism in adi-
pose tissue is an important next step toward our understanding
of the actions of this gene.
Here, we show that Nat1 is not only strongly co-regulated with
key mitochondrial genes but also that Nat1 deficiency causes
significant decreases in multiple indices of mitochondrial func-
tion in vitro as well as global lipid metabolism alterations in vivo.
Furthermore, Nat1-deficient mice have a marked decrease in
basal metabolic rate and exercise capacity. Taken together,
these data suggest that mitochondrial dysfunction may be a
cellular mechanistic link among Nat1, insulin sensitivity, and
whole-body energy expenditure.
RESULTS
Characterization of Nat1-Deficient Mice on Regular
Chow
A significant increase in mean body weight was observed in the
Nat1 knockout (Nat1 KO) mice compared to their wild-type (WT)
littermate controls after 15 weeks on a regular chow diet (Fig-
ure 1A), despite no difference in food or water intake (data notell Reports 17, 527–540, October 4, 2016 ª 2016 The Authors. 527
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Metabolic Characterization of Nat1-Deficient Mice
(A–C) Body weight (A), epididymal fat (B), and liver weights (C) of wild-type (WT) and Nat1-deficient mice (KO) at 16 weeks fed a chow diet (n = 10–15 mice per
group). Values are mean ± SEM.
(D) H&E staining of epididymal WAT of WT and Nat1-deficient mice is shown. Scale bar, 100 Pi (103 magnification).
(E–G) Plasma adiponectin (E), leptin (F), and FFA concentrations (G) were determined inmice fasted overnight (n = 10–13 per genotype). Values representmeans ±
SEM (***p% 0.001, **p% 0.01, and *p < 0.05).
(H and I) Gene expression profiling in WAT in WT and Nat1 KO mice (n = 5–6 mice per group) using real-time qPCR for expression of genes involved in lipid
metabolism (H) and for inflammatory markers (I). The expression values were normalized to cyclophilin. Results represent mean ± SEM (**p% 0.01 and *p < 0.05).shown). The weights of epididymal fat and liver were significantly
increased in Nat1 KO mice compared to those of the control
mice (Figures 1B and 1C), and H&E staining of epididymal fat tis-
sue revealed that Nat1-deficient mice exhibit larger adipocytes
compared to the WT controls (Figure 1D). The increased
adiposity in Nat1 KO mice was accompanied by a decrease in
the adipose expression of adiponectin (Adipoq), mirrored by a
17% decrease in plasma adiponectin levels (Figure 1E), while
there was a non-significant increase in plasma leptin levels (Fig-
ure 1F). Livers of Nat1-deficient mice exhibited increased intra-
hepatic triglyceride content on regular chow (Figures S1A and528 Cell Reports 17, 527–540, October 4, 2016S1B) compared with control mice. No differences were observed
in liver enzymes (Figures S1C and S1D).
Free fatty acid (FFA) concentrations were comparable be-
tween Nat1 KO and WT mice (Figure 1G), despite elevated
plasma triacylglycerol (TG) levels in the Nat1 KO mice (Knowles
et al., 2015). The mRNA levels of important genes involved in
lipogenesis and FFA transport (e.g., Srebp1, Fas, and Cd36)
were not significantly elevated in Nat1-deficient mice. As
expected given the decreased insulin sensitivity observed in
Nat1 KO mice, the expression of Glut4 was also significantly
decreased in Nat1 KO mice (Figure 1H).
Figure 2. Effect of Nat1 Deficiency on Fasting Plasma Metabolome and Lipidome
(A) Hierarchical clustering of significantly different metabolites and lipids in fasting plasma from non-targeted metabolomics and lipidomics experiments
(FDR < 0.1). Signal intensities were clustered in two dimensions (horizontal, metabolites and lipids; vertical, samples) on the basis of Euclidean distance. Colors
indicate metabolite/lipid abundance as high (red), median (white), or low (blue).
(B–E) Values are normalized to the median and expressed as box-and-whisker plots (n = 9–11; *p% 0.05, **p% 0.01, and ***p% 0.001). AC, acylcarnitine; DG,
diacylglycerol; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; SM, sphingomyelin; TG, triacylglycerol. The list of significantly
changing metabolites and lipids is given in Table S1. Data obtained from non-fasting plasma samples are shown in Figure S2.In addition, we found increased expression of the pro-inflam-
matory markers Tnfa, Il-1b, andMcp1 (Ccl2) in adipose tissue of
Nat1 KO mice compared to WT littermates (Figure 1I), whereas
there was no difference in the Il-10 expression levels between
the groups.
Effects of Nat1 Deficiency on Plasma Metabolome and
Lipidome
We performed a comprehensive metabolite and lipid profiling of
fasting plasma from WT and Nat1 KO mice using a broad-spec-
trum liquid chromatography coupled with mass spectrometryplatform (Contrepoiset al., 2015).Comparativeanalysisof theme-
tabolites and lipids revealed that lipidmetabolismwas profoundly
perturbed in Nat1 KO mice compared to the WT littermate con-
trols. In particular, the plasma levels of 51 phospholipids, 30 lyso-
phophospholipids, 20 glycerolipids, and 11 acylcarnitines were
decreased inNat1KOmice compared toWT littermatemice (Fig-
ure 2A). Similar changes were observed in non-fasting plasma,
despite more inter-individual variability due to small differences
inpostprandial timingafterwhich thebloodwasdrawn (FigureS2).
Short-chain (C2, C4OH, C6, and C6DC), medium-chain (C10:1
and C10:3), and long-chain (C14, C14:2, C16:0, C18:1, andCell Reports 17, 527–540, October 4, 2016 529
C18:2) acylcarnitines, intermediates of fatty acid oxidation, were
diminished in the plasma of Nat1 KO mice, suggesting remodel-
ing of the oxidative phosphorylation (OXPHOS) process and
changes in lipid oxidation (Figure 2B). Interestingly, most of the
significantly deregulated lipids contained essential linoleic acid
(18:2), such as lysophosphatidylcholine (LPC) (18:2), lysophos-
phatidylethanolamine (LPE) (18:2), phosphatidylcholine (PC)
(14:0/18:2), PC (16:0p/18:2), TG (18:2/20:4/22:6), and TG (18:3/
18:2/22:6) (Figures 2C and 2D; Table S1). In addition to lipid
metabolism, 19 amino acids and derivatives were significantly
reduced inNat1-deficient mice. Pathway analysis revealed a sig-
nificant alteration of arginine and proline metabolism (false dis-
covery rate [FDR] = 0.0035), among which L-proline, ornithine,
L-glutamic acid, and L-arginine are key metabolites (Figure 2E).
Glycine, serine, and threonine metabolism also was signifi-
cantly altered (FDR = 0.0301). Interestingly, derivatives of L-argi-
nine (homoarginine, N,N-dimethylarginine) along with L-lysine
and N6-acetyl-L-lysine also were significantly decreased. An
exhaustive list of the metabolites and lipids significantly altered
upon Nat1 knockdown can be found in Table S1.
Nat1 Expression in Adipose Is Co-regulated with
Mitochondrial Genes
To provide insight into the metabolic pathways interacting with
Nat1, we examined co-expression gene networks in adipose tis-
sue collected from a large mouse cohort that segregated for
obesity-induced diabetes (Tian et al., 2015; Tu et al., 2012).
Gene ontology (GO) and Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) pathway analyses were performed to identify the
molecular functions and biological processes of genes that
correlated with Nat1 expression. Interestingly, genes that posi-
tively correlatedwithNat1 expression were significantly enriched
for biological processes associated with mitochondrial biology,
glucose metabolism, and energy balance (Figures S3A and
S3B). Genes that negatively correlated with Nat1 expression in
adipose significantly enriched for growth factor binding and
extracellular matrix (Figure S3C). The list of mitochondrial genes
most positively correlated withNat1 expression in adipose tissue
is shown in Table S2.
Loss of Nat1 Decreases Mitochondrial Function in
3T3-L1 Adipocytes
Based on data indicating that Nat1 is strongly co-regulated with
mitochondrial pathway genes, we sought to comprehensively
evaluate mitochondrial function resulting from the perturbations
of Nat1. Increased reactive oxygen species (ROS) production is
often observed in mitochondrial dysfunction and IR (Sivitz and
Yorek, 2010). ROS was measured using 20,7’-dichlorodihydro-
fluorescein diacetate (H2DCFDA). Knockdown of Nat1 in 3T3-
L1 adipocytes markedly induced ROS production (1.3-fold)
and strongly elevated the production of mitochondrial superox-
ide (O2
–), a major source of mitochondrial ROS when evaluated
with Mitosox Red (Figures 3A and 3B). Because the electro-
chemical gradient of the mitochondrial membrane is essential
for ATP synthesis, we monitored mitochondrial membrane po-
tential by fluorescence microscopy. Cells were stained with Tet-
ramethylrhodamine methyl ester (TMRM), imaged with a fluores-
cent microscope, and the intensity of TMRM fluorescence was530 Cell Reports 17, 527–540, October 4, 2016determined (Figure 3C). We found that Nat1 silencing resulted
in a decrease of mitochondrial membrane potential of 30%,
suggesting that loss of Nat1 markedly induced mitochondrial
membrane depolarization in adipocytes from 3T3-L1 cells.
Loss of membrane potential was further verified using a fluores-
cent plate reader, which showed a decreased membrane poten-
tial of 30% (Figure 3D).
Nat1 Deficiency Decreases Mitochondrial Mass and
Biogenesis in Adipocytes
Toexplorewhether the loss ofNat1affectsmitochondrial number
and biogenesis, we measured mitochondrial mass using a fluo-
rescent probe, MitoTracker deep red. Intensity of MitoTracker
fluorescence was analyzed by flow cytometry and was further
verified by confocal imaging (Figures 3E and 3F). Loss of Nat1
significantly decreased mitochondrial mass by 22%. We then
measured the expression of peroxisome proliferator-activated
receptor gamma coactivator-1-alpha (Pgc1a) (Ppargc1a), a tran-
scriptional co-activator implicated in mitochondrial biogenesis
and adaptive thermogenesis.Pgc1awas significantly downregu-
lated at both mRNA and protein levels in the knockdown group
compared to controls (Figures 3G and 3H). To further explore
the changes in mitochondrial biogenesis and oxidative phos-
phorylation, we also assessed the levels of key regulators of
mitochondria by real-time qPCR. Nrf1, Tfam, Cycs, and Pgc1b
were significantly downregulated in the Nat1 knockdown group
compared to controls, which is consistent with the in vivo results
(Figure 3I). Our findings suggest that the loss of Nat1 decreases
mitochondrial mass and biogenesis in 3T3-L1 adipocytes.
Given these findings, we also assessed the expression of
genes involved in mitochondrial biogenesis and oxidative phos-
phorylation in white adipose tissue (WAT) of WT and Nat1-defi-
cient mice. The deletion of Nat1 significantly decreased the
expression of Pgc1a and cytochrome c (Cycs) (Figure S3D).
Nat1 Knockdown Promotes Drp1-Dependent
Mitochondrial Fragmentation
We evaluated the effect of Nat1 knockdown on the regulation
of mitochondrial dynamics by performing confocal microscopy
on 3T3-L1 cells and assessing morphology with MitoTracker
Red CMXRos. Mitochondrial fragmentation is a morphological
phenotype normally associated with dysfunctional mitochon-
dria, such as with ischemic reperfusion injury (Disatnik et al.,
2013). We observed a marked increase in mitochondrial frag-
mentation inNat1 KO cells compared to the controls (Figure 4A).
Mitochondrial fragmentation can occur by a number of mecha-
nisms, including increased mitochondrial fission, decreased
mitochondrial fusion, or decreased mitophagy (Dorn, 2015).
We first examined dynamin 1-like protein (Drp1) (Dnm1l) expres-
sion in 3T3-L1 adipocytes by western blot, since Drp1 is the key
regulator of mitochondrial fission. Knocking down Nat1 in 3T3-
L1 adipocytes led to a significant increase of Drp1 in the mito-
chondrial fraction by 1.6-fold (Figure 4B). We then measured
the levels of the mitochondrial fusion proteins Mfn1 and Mfn2
and mitophagy proteins Lc3a/b and Pink1, and we found no
difference between groups (Figures 4C and 4D).
We also measured mitochondrial markers in isolated mito-
chondrial fractions from WAT of WT and Nat1-deficient mice.
Figure 3. Effect of Nat1 Knockdown on
Mitochondrial Functions
(A) Intracellular ROS was measured using
H2DCFDA in 3T3-L1 adipocytes transfected with
scrambled siRNA (scr siRNA) or with siRNA
against Nat1 (si Nat1).
(B) Mitochondrial superoxides were measured by
fluorescence microscopy in 3T3-L1 adipocytes
transduced with lentiviral controls and sh Nat1
stained with MitoSOX Red (10 mM) (43 magnifi-
cation). Mitochondrial membrane potential (DJm)
was monitored using TMRM staining (50 nM) in
3T3-L1 adipocytes.
(C) Fluorescent microscopic analysis (203
magnification) and intensity of TMRM were
quantified.
(D)Membrane potential was further analyzed using
fluorescent plate reader. Data are presented as
mean ± SEM of three separate experiments, with
eight wells per condition. Mitochondrial mass was
measured in 3T3-L1 adipocytes transduced with
lentivirus controls and sh Nat1 using MitoTracker
deep red (100 nM).
(E) Fluorescence was analyzed by flow cytometry.
Values are mean ± SEM of triplicates of three
different experiments (**p% 0.01).
(F) Confocal microscopy in 3T3-L1 adipocytes is
shown.
(G) The qPCR analysis of Pgc1a expression in 3T3-
L1 adipocytes. Data represent mean ± SEM.
(H) Western blot analysis of Pgc1a protein levels in
differentiating mouse 3T3-L1 adipocytes is shown.
(I) The qPCR analysis of mitochondrial genes
in 3T3-L1 adipocytes normalized to cyclophilin.
Representative results are shown of three experi-
ments. Data are presented as mean ± SEM (*p <
0.05, **p% 0.01, and ***p < 0.001).Nat1 deficiency increased Drp1 expression (Figure 4E). Electron
microscopy of WAT showed smaller and more circular mito-
chondria in Nat1 KO mice compared with WT mice (Figure S4).
Taken together, these data indicate that the deficiency of Nat1
is associated with mitochondrial fragmentation mediated by
Drp1-dependent mechanisms of mitochondrial fission and re-
sults in significant changes to the morphology and number of
mitochondria, which also are observed in vivo.
Nat1 Silencing Decreases Cellular Respiration and ATP
Generation in Adipocytes
Given that impaired mitochondrial respiration has been linked to
the development of IR, we measured in situ respiratory capacityCellusing the XF24 Seahorse extracellular flux
analyzer with cultured adipocytes. Respi-
ration rates were calculated as a function
of changes in the oxygen consumption
rate (OCR) in response to oligomycin,
carbonyl cyanide 4-trifluoromethoxyphe-
nylhydrazone (FCCP), and antimycin/
rotenone. Nat1-silenced cells had a
reduced OCR relative to control adipo-
cytes (Figure 5A). The results of the respi-ration studies indicated that Nat1 knockdown adipocytes had
decreased basal and maximal respiration by 18% and 26%,
respectively, compared to the control adipocytes (Figure 5B).
Extracellular acidification rate (ECAR) also was measured as
an index of lactate production. We found no difference in the
basal acidification rate; however, the maximal acidification rate
was decreased in Nat1 knockdown adipocytes compared to
the controls (Figures S5A and S5B).
Decreased cellular respiration was further verified in WAT of
WT and Nat1-deficient mice using an Oroboros Oxygraph-2k
respirometer. Nat1 deficiency significantly decreased basal
respiration (Figure 5C). Decreased OCR was accompanied by a
significant decrease in mtDNA content in WAT of Nat1-deficientReports 17, 527–540, October 4, 2016 531
Figure 4. Effect of Nat1 on Mitochondrial Dynamics in 3T3-L1 Adipocytes
Nat1 knockdown increased mitochondrial fission/fragmentation
(A) Confocal imaging shows mitochondrial fragmentation in 3T3-L1 adipocytes transduced with lentivirus for controls and sh Nat1 stained with MitoTracker Red
CMXRos (100 nM) and analyzed for mitochondrial area, perimeter, circularity, and interconnectivity.
(B) Western blot analysis of mitochondrial proteins for mitochondrial fission quantified by ImageJ. Values are mean ± SEM of two different experiments
(*p% 0.05).
(C and D) Fusion (C) and mitophagy (D) in isolated mitochondrial and cytosolic fractions from 3T3-L1 adipocytes transduced with lentivirus for controls and sh
Nat1 are shown.
(E) Mitochondrial markers in isolated mitochondrial fractions from WAT of WT and Nat1-deficient mice are shown (n = 4).
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Figure 5. Effect of Nat1 Ablation on Cellular Respiration and ATP Production in Differentiated 3T3-L1 Adipocytes
(A) Oxygen consumption rate (OCR) was measured using the XF24 Extracellular Fluid Analyzer in 3T3-L1 adipocytes transduced with control pLV and sh Nat1.
(B) Basal respiration and maximal respiration rates were determined from (A) (n = 9–10; **p% 0.01 and ***p < 0.001).
(C and D) OCR (C) and mtDNA content (D, mtDNA/nDNA) were measured in WAT of WT and Nat1-deficient mice (n = 5; *p% 0.05).
(E) Cellular ATP levels were measured in 3T3-L1 adipocytes. Data are presented as mean ± SEM of three separate experiments, with five wells per experiment
(*p% 0.05).mice compared to WT controls, thus indicating a decreased
number of mitochondria in the WAT of Nat1 KO mice, which is
consistent with decreased mitochondrial mass and biogenesis
in 3T3-L1 adipocytes lacking Nat1 expression (Figure 5D).
These data suggest that the inhibitionofNat1 is associatedwith
impaired cellular respiration. Given that respiration was signifi-
cantly affected by Nat1 deficiency, we next assessed the cellular
ATP concentrations, and we found that Nat1 knockdown in 3T3-
L1 adipocytes resulted in a decrease of total cellular ATP levels
by 24%, suggesting that the loss of Nat1 markedly decreased
overall mitochondrial function and ATP generation (Figure 5E).
Nat1 KO Mice Display Decreased Metabolic Rate and
Energy Expenditure
Given the effect of Nat1 on mitochondrial function and the
observed effect on plasma metabolites and lipids, we hypothe-
sized that Nat1 deficiency would be associated with changes
in basal metabolic rate. To better understand the role of Nat1
in whole-body energy expenditure under basal conditions, we
subjected 4-month-oldWT andNat1-deficient mice fed a normalchow diet to indirect calorimetry analysis in metabolic cages for
24 hr. Nat1 KO mice exhibited increased respiratory exchange
ratio (RER) (Figure 6A) and decreased whole-body OCR (VO2)
(Figure 6B), suggesting an inability to switch from carbohydrate
to fat metabolism. Overall resting energy expenditure was
significantly decreased in Nat1 KO mice compared to WT mice
(Figure 6C).
Nat1-Deficient Mice Are Cold Tolerant
Given thatNat1 deficiency was associated with changes in basal
metabolic rate, a reasonable hypothesis is that Nat1 deficiency
also would have a primary effect on thermogenesis. Therefore,
we assessed fuel metabolism by indirect calorimetry for 24 hr.
Heat production was measured in 4-month-old WT and Nat1-
deficient mice fed a normal chow diet for 24 hr. Over the course
of 24 hr, the percentage of energy generated from fatty acid
oxidation was less than carbohydrate metabolism in Nat1 KO
mice (Figures 6D and 6E).
Brown adipose tissue (BAT) is involved in the generation of
heat by burning lipids. BAT is activated during cold exposureCell Reports 17, 527–540, October 4, 2016 533
Figure 6. Decreased Metabolic Rate in Nat1 KO Mice
(A–C) RER (A), VO2 (B), and energy expenditure (C) were measured in 4-month-old WT and Nat1-deficient mice given a normal chow diet for 24 hr (n = 4 mice per
group; ***p% 0.001).
(D and E) Heat production was measured for 24 hr in 4-month-old WT and Nat1-deficient mice given a normal diet for 24 hr (n = 4).
(F) H&E staining of BAT of WT and Nat1-deficient mice (n = 4) is shown.
(G) Thermogenic gene expression in BAT of WT and Nat1-deficient mice (n = 3), normalized to cyclophilin. Results represent mean ± SEM.
(H) Core body temperature was measured in 4-month-old WT and Nat1-deficient male mice fed a chow diet (n = 5–8 mice).
(I) Rectal temperature was measured every 30 min for 4 hr after exposure to a 4C environment (n = 5–8 mice).
(J and K) Blood glucose (J) and non-esterified fatty acids in plasma (K) were measured in WT and Nat1-deficient mice (*p% 0.05, **p% 0.01, and ***p% 0.001).to maintain core body temperature. Histological analysis of BAT
from WT and Nat1 KO mice did not show differences in lipid
accumulation under basal conditions (Figure 6F). However, abla-
tion of Nat1 resulted in reduced expression of the major thermo-534 Cell Reports 17, 527–540, October 4, 2016genic genes, including Pgc1a, uncoupling protein 1 (Ucp1), and
cell death-inducing DFFA-like effector A (Cidea) (Figure 6G). We
also assessed their basal core body temperature and found no
difference between the WT and Nat1-deficient mice (Figure 6H).
Figure 7. Nat1 Deficiency on Energy Expenditure and Cardiac Phenotype In Vivo
(A–D) Mean RER (A), exercise capacity (B), time to exhaustion (C), and baseline and maximal VO2 were determined during exercise by treadmill protocol. Values
are the means ± SEM of n = 8 mice per group (*p% 0.05, **p% 0.01, and ***p% 0.001).
(E) Representative electron micrographs show the hearts of 4-month-old mice. Scale bar, 2 mm.
(F and G) Mitochondrial number and area were quantified blindly from eight to ten images from different fields (n = 4; ***p% 0.001).
(H) OCR of heart-isolated mitochondria was assessed using an Oroboros Oxygraph-2k respirometer (n = 5–7 mice per group; **p% 0.01).
(I) Relative mtDNA content was measured in cardiac muscle of WT and Nat1-deficient mice (n = 3).
(J) Mitochondrial markers in isolated mitochondrial fractions from hearts of WT and Nat1-deficient mice (n = 4) are shown.To investigate a possible role for Nat1 in BAT function, we
exposed Nat1 KO and WT mice to a cold (4C) environment for
4 hr in order to activate BAT. Rectal temperature was measured
every 30 min. The Nat1-deficient mice had no difference in
core body temperature following cold exposure compared to
WT mice (Figure 6I). Circulating glucose and FFAs also were
measured before and after the cold challenge. Nat1-deficient
mice exhibited a marked increase in blood glucose levels but
no change in the plasma FFAs after cold exposure (Figures 6J
and 6K). Together, these results suggest that Nat1 deficiency
is associated with a preferential use of carbohydrates over fats
as fuel both under basal and cold-challenge conditions and
potentially a reduction in FFA release.
Nat1 Deletion Impairs Exercise Capacity and Cardiac
Mitochondrial Respiration in Nat1 KO Mice
Given that mitochondrial function is a key determinant of exer-
cise capacity, we sought to evaluate whether Nat1 deficiency
would be accompanied by decreased exercise tolerance. Wesubjected 12- to 14-week-old Nat1 KO and WT littermate mice
on a normal chow diet to a treadmill exercise challenge. Nat1-
deficient animals exhibited a 19% decrease in exercise ca-
pacity, a 23% decrease in time to exhaustion, a lower anaerobic
threshold, and a 14% decrease in VO2 maximum compared to
their WT controls (Figures 7A–7D).
To examine the possibility that the decreased exercise capac-
ity in Nat1-deficient mice can be attributed to effects on cardiac
mitochondria, we performed electron microscopic analyses of
heart tissue, which showed smaller mitochondria in Nat1 KO
mice compared with WT mice (Figures 7E–7G). Lipid droplets
were present among mitochondria in KO mice (data not shown).
Oxygen consumption was significantly decreased in cardiac
mitochondria fromNat1KOmice versus control mice (Figure 7H).
However, no changes were observed in the mitochondrial DNA
content (Figure 7I). We also measured mitochondrial markers
in isolatedmitochondrial fractions from hearts.Nat1KOmice ex-
hibited increased expression of mitochondrial fission marker
Drp1 (Figure 7J).Cell Reports 17, 527–540, October 4, 2016 535
We also examined cardiac function inNat1 KO andWTmice in
the resting state with echocardiography. There was no change in
left ventricular internal diameter (LVID) or percentage fractional
shortening (FS%) in the Nat1 KO mice compared with control
animals (Figure S6). All echocardiography measurements are
shown in Table S3.
Given that skeletal muscle is also a major determinant of en-
ergy expenditure, we assessed whether global deficiency of
Nat1 is associated with functional defects in skeletal muscle
mitochondrial function. C2C12 myoblasts with Nat1 knockdown
had significantly decreased cellular respiration (Figure S7A).
Furthermore, Nat1 KO mice exhibited smaller and increased
numbers of mitochondria per tibialis muscle fiber (Figures
S7B–S7D) and increased expression of mitochondrial fission
marker Drp1 compared to the WT mice (Figure S7E).
DISCUSSION
Our findings link deficiency of the IR gene Nat1 to profound
mitochondrial dysfunction characterized by an enhanced accu-
mulation of ROS and superoxides (O2
–), an increase in mito-
chondrial membrane depolarization, decreased basal and
maximal cellular respiration, and decreased ATP production.
Though our most detailed characterization was performed in
3T3-L1 adipocytes and WAT, the major observations of mito-
chondrial dysfunction were extended to skeletal muscle cells
(C2C12 myoblasts) and tissue as well as cardiac cells. In addi-
tion, our in vivo observations suggest that mitochondrial
dysfunction seen in Nat1 KO mice is accompanied by a
decrease in basal respiration and exercise capacity. Finally,
multiple lines of evidence suggest a dysregulation in the ability
to utilize fats for energy.
Thus, this study provides a specific genetic mechanism (Nat1
deficiency) that may help explain prior observations that tied
mitochondrial dysfunction and impaired biogenesis with IR and
abnormal glucose homeostasis (Handschin et al., 2007; Johnson
and Olefsky, 2013; Kelley et al., 2002; Kim et al., 2000; Kleiner
et al., 2012; Morino et al., 2006; Petersen et al., 2004; Schrauwen
and Hesselink, 2004; Vianna et al., 2006). Furthermore, our find-
ings also suggest a means to partly explain the co-occurrence
of mitochondrial dysfunction in adipose tissue in animal models
of T2D as well as in human obesity, T2D, and the metabolic syn-
drome (Bogacka et al., 2005a, 2005b; Choo et al., 2006; Patti and
Corvera, 2010).
This mitochondrial dysfunction could be due to decreased
mitochondrial number/mass or decreased mitochondrial effi-
ciency. Our results suggest that both of these processes are
affected by Nat1 deficiency. Mitochondrial mass was mark-
edly reduced as were master regulators of mitochondrial
biogenesis and function, such as Pgc1a and Pgc1b, nuclear
respiratory factor 1 (Nrf1), and mitochondrial transcription
factor A (Tfam). Mitochondria constantly fuse and divide, pro-
cesses known as fusion and fission, and excessive mitochon-
drial fragmentation induces mitochondrial dysfunction. In
our study, we observed a significant increase in mitochon-
drial fragmentation and Drp1 expression in Nat1 KO cells
compared to the controls, indicating that the deficiency of
Nat1 triggers mitochondrial fragmentation by increasing536 Cell Reports 17, 527–540, October 4, 2016Drp1. In addition, selective thermogenic genes in BAT were
significantly decreased in Nat1-deficient mice compared with
WT controls, which also may reflect effects on Pgc1a. Finally,
key parts of the electron transport chain and ATP generation,
e.g., Cycs, were significantly downregulated in Nat1-deficient
cells and WAT.
Nat1-associated mitochondrial dysfunction may be primary or
secondary (for instance, related to mitochondrial substrate
availability). While the former is likely, as outlined above, it is
difficult to exclude the latter. As an example, we found that
fasted Nat1 KO mice have markedly reduced levels of multiple
plasma acylcarnitines. Acylcarnitines result from the addition
of a carnitine molecule to an activated FFA, a prerequisite for
FFA to be transported into the mitochondria and undergo
b-oxidation. Together with the fact that Nat1 KO mice have an
inability to utilize fatty acids, it suggests that Nat1 deficiency is
associated with an impaired fatty acid transportation and/or
b-oxidation. The resulting diminution in acylcarnitines is a
common feature of IR (Noland et al., 2009). However, it is not
yet clear whether acylcarnitines are reflecting or inflicting IR
(Schooneman et al., 2013).
Nat1 deficiency is also associated with the reduction of
numerous lysophospholipids, phospholipids, glycerolipids, and
amino acids that are consistent with an IR phenotype (Roberts
et al., 2014). Interestingly, deregulated lipids often contain lino-
leic acid 18:2. LPC (18:2) is a well-known negative correlate of
IR, dysglycemia, and diabetes (Ferrannini et al., 2013; Floegel
et al., 2013; Gall et al., 2010; Wang-Sattler et al., 2012), and
LPCs have been shown to be reduced in obesity and T2D (Kim
et al., 2011, 2013; Wang-Sattler et al., 2012). The global
decrease of phospholipids may be due to a reduced biosyn-
thesis, because phospholipid precursors choline, phosphor-
ylcholine, and sn-glycero-3-phosphoethanolamine also were
found in lower quantities in the plasma of Nat1 KO mice.
The arginine and proline metabolism (L-aspartic acid, L-argi-
nine, creatine, ornithine, L-proline, and L-glutamic acid) pathway
was the most significantly deregulated upon Nat1 depletion.
Most of these metabolites have been associated with obesity
and diabetes (Giesbertz et al., 2015). We also found a reduction
in the quantity of glycine in Nat1 deficiency that is a well-estab-
lished negative correlate to diabetes and obesity (Ferrannini
et al., 2013; Giesbertz et al., 2015; Newgard et al., 2009;
Wang-Sattler et al., 2012). Altogether these results suggest
that Nat1 deficiency destabilizes energy homeostasis.
This altered homeostasis also is manifested in other ways.
Nat1-deficient mice accumulate more fat in the form of WAT
depots and liver TG without a change in daily food intake or
changes in FFA levels or expression levels of genes involved in
lipogenesis, which include fatty acid synthase (Fas) and sterol
regulatory element-binding protein 1 (Srebp1). The increased
adiposity could reflect a decrease in energy expenditure. In
this regard, we observed that Nat1 deficiency significantly
decreased the expression of Ucp1 and related thermogenic
genes (Cidea and Pgc1a) in BAT, suggesting decreased thermo-
genesis (Enerba¨ck et al., 1997; Matthias et al., 2000; Ricquier
and Bouillaud, 2000; Wolf, 2009) and Ucp1 ablation, which
induces obesity (Feldmann et al., 2009). Nat1 KO mice also
seem to derive less heat from fatty acid oxidation. Assessment
of the animals’ responses to acute cold exposure showed that
the Nat1 KO mice have a diminished FFA response but a more
profound elevation in glucose compared to WT mice. However,
these experiments did not reveal any gross thermogenic impair-
ment in the Nat1 KO mice, as they maintained their core body
temperature equal to WT mice.
Such an acute challenge of mice previously housed at room
temperature triggers a response in which all available heat-
generating tissues are maximally activated. In such animals
this consists of a combination of shivering (muscle dependent)
and previously adapted uncoupled thermogenesis (BAT depen-
dent) (Cannon and Nedergaard, 2011). While our cold challenge
data do not distinguish between the relative contribution of
muscle and BAT to the maintenance of heat, they strongly
suggest that a primary defect in the thermogenic capacity or
functionality of BAT is not causative of the change in energy
balance observed in the Nat1 KO mice. Such severe impedi-
ments to BAT thermogenesis usually result in a more marked
drop in core body temperature following this type of challenge
(Lee et al., 2015). Subtler impairments to the efficiency of
BAT or compensatory increases in muscle-shivering capacity,
caused by the previously highlighted changes to substrate
availability and with the potential to impact energy balance,
cannot be ruled out. However, longer-term chronic cold expo-
sure and perhaps tissue-specific KO models would likely be
required to dissect such adaptive changes in the Nat1 KO
mouse.
A key finding in the current study is that WT mice run longer
than Nat1-deficient mice. The decreased endurance in Nat1-
deficient mice is accompanied by decreased VO2. Decreased
exercise endurance inNat1-deficientmice suggests reduced ox-
ygen-dependent respiration during exercise. This is supported
by the fact that Nat1-deficient mice reach anaerobic threshold
sooner than the control mice (Figure 7C).
Impaired exercise capacity is a predictor of IR, T2D, cardio-
vascular diseases, and overall mortality (Church et al., 2004;
Fang et al., 2005), and mitochondria play a key role in the
response to exercise challenge. The mitochondrial dysfunction
seen in Nat1 deficiency is likely contributing to the observed
decreased exercise capacity in Nat1 KO mice (Figure 7).
Furthermore, Nat1 KO mice also had a higher resting RER
and decreased basal energy expenditure versus WT mice (Fig-
ure 6), suggesting that Nat1 deficiency may involve preferen-
tial use of inefficient carbohydrate over fats as fuel during
resting and active states. Our observations linking Nat1 defi-
ciency to insulin sensitivity, mitochondrial function, and exer-
cise capacity demonstrate the interconnectedness of these
phenotypes.
In conclusion, our data reveal a metabolic function of Nat1
that triggers mitochondrial dysfunction and is accompanied by
changes in cellular respiration that are correlated at a whole-
body level with decreased basal energy expenditure and exer-
cise tolerance. These findings shed light on the cellular mecha-
nistic link amongNat1, IR, andmitochondrial function. Additional
research may identify new treatment approaches targeting mito-
chondria. The link between insulin sensitivity and mitochondria
may be a fruitful area of discovery as new IR loci are being
identified.EXPERIMENTAL PROCEDURES
Animals
Nat1-targeted mice (Nat1 KO) were produced as described previously
(Knowles et al., 2015). Mice were housed in a pathogen-free barrier facility
with a 12-hr light/dark cycle, and they were fed standard rodent chow diet
and water ad libitum. Male mice between 3 and 4 months old were used in
all the experiments.
Systemic Metabolic Parameters
Overnight fasting blood samples were collected by retro-orbital bleeding from
anesthetized mice and EDTA plasma was prepared immediately. Plasma
concentrations of adiponectin (Crystal Chem), leptin (Crystal Chem), insulin
(Crystal Chem), and FFA (Wako Diagnostics) were determined enzymatically
according to the manufacturers’ protocols. Overnight fasting blood glucose
levels from the tail veinweremeasuredwith a glucometer (TRUEbalance, Nipro
Diagnostics).
Study Approval for Animal Work
All animal protocols were approved by the Administrative Panel on Laboratory
Animal Care at Stanford University, and they were performed in accordance
with the guidelines of the American Association for the Accreditation of Labo-
ratory Animal Care.
Histology
Histological analysis was performed according to standard protocols for
paraffin-embedded samples.
Cell Culture
The murine 3T3-L1 and C2C12 myoblasts were obtained from American Type
Culture Collection, cultured and differentiated according to the manufacturer’s
instructions. Details are given in the Supplemental Experimental Procedures.
Nat1 Knockdown Using siRNA in 3T3-L1 Adipocytes
For knockdown experiments, differentiated 3T3-L1 adipocytes were trans-
fected with 50 nM synthetic predesigned small interfering RNA (siRNA) target-
ing Nat1 or non-silencing siRNA (scr siRNA) (OriGene) using lipofectamine
2000 transfection reagent (Life Technologies), following the manufacturer’s
recommended protocol. After 48 hr of transfection, the media were changed.
Nat1 Knockdown Using Lentiviral Constructs
Cells were transduced with a combination of lentiviral particles for two knock-
down constructs at an MOI of 100 each. After overnight incubation, medium
containing viral particles was removed and replaced with fresh medium. The
transduction efficiency was assessed by quantifying the percentage of GFP-
positive cells by flow cytometry on a BD FACS Calibur. Nat1 knockdown effi-
ciency was confirmed by qPCR.
RNA Extraction, Reverse Transcription, and Real-Time PCR
RNA extraction, reverse transcription, and real-time PCR were performed as
described in the Supplemental Experimental Procedures. Primer sequences
are given in Table S3. The gene expression values were normalized to cyclo-
philin A as a housekeeping gene. The data were analyzed by the public domain
program Relative Expression Software Tool – REST. Values are presented as
mean ± SEM (Chennamsetty et al., 2011).
Protein Extraction and Immunoblotting
Immunoblotting was performed as described in the Supplemental Experi-
mental Procedures. The primary antibodies used were as follows: LC3A/B
(Cell Signaling Technology), Porin/anti VDAC1 (Abcam), Drp1 (BD Transduc-
tion Laboratories), Pgc1a (H 300), PINK1, b-actin (Santa Cruz Biotechnology),
Mfn1 (Abcam), and Mfn2 (Abnova).
Intracellular ROS
Intracellular ROS generation was determined using H2DCFDA (10 mM, Sigma-
Aldrich), as per the manufacturer’s protocol. In brief, adipocytes were washed
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and fluorescence was measured using a microplate reader (Tecan) with exci-
tation/emission wavelengths of 485/515 nm.
Mitochondrial Superoxide Measurement
MitoSOX Red (Molecular Probes) was used to measure mitochondrial specific
superoxide. Cells were stained, washed twice with PBS, and live cell images
were taken using a fluorescence microscope.
Mitochondrial Membrane Potential, DJm
Mitochondrial membrane potential was measured using a TMRM kit (Abcam).
The 3T3-L1 cells in 96-well black-walled culture plates were incubated with
100 nM TMRM for 20 min at 37C in PBS containing 0.2% BSA. After the cells
were washed, the TMRM fluorescence was monitored using a fluorescent mi-
croscope and the cells were imaged. Membrane potential was further verified
using a fluorescent plate reader (Tecan). The excitation and emission wave-
lengths were set at 445 and 580 nm, respectively.
ATP Production Assay
The ATP content of the adipocytes was measured using a Luminescent
ATP Detection Assay Kit (PerkinElmer) according to the manufacturer’s
protocol. Cells were mixed with the detection reagent, and luminescence
was measured, using a 10-s integration time with a microplate luminometer
and SOFTmax PRO software (Molecular Devices), and normalized to protein
concentration.
mtDNA Content
Genomic DNA was isolated from tissues of WT and Nat1 KO mice (n = 5 per
group) using the DNeasy Blood & Tissue Kit (QIAGEN), following the manufac-
turer’s instructions. ThemtDNA content was assessed by real-time qPCR. The
relative mtDNA content was evaluated by the ratio of DNA levels between
mitochondrial Cox1 and nuclear 18S rRNA.
Mitochondrial Mass Measurement
3T3-L1 adipocytes were incubated with 50 nM MitoTracker Deep Red FM
(Invitrogen) in serum-free DMEM for 30 min at 37C. Cells were then washed
thoroughly with PBS, trypsinized, centrifuged, and resuspended in PBS. Fluo-
rescent intensity was analyzed using a FACS Calibur (BD Pharmingen).
Confocal Laser Microscopy for Visualizing Mitochondria
3T3-L1 adipocytes were transduced with lentivirus for controls and sh Nat1
was stained with mitochondria-specific fluorescent dye, MitoTracker Red
CMXRos (100 nM), then fixed in 4% paraformaldehyde, and mitochondria
were visualized by confocal microscopy and analyzed for area, perimeter,
circularity, and interconnectivity by ImageJ.
XF24 Oxygen Consumption Assay and Bioenergetics Profile
Oxygen consumption was measured using the XF24 extracellular flux analyzer
from Seahorse Bioscience according to their protocol. Cells were seeded in a
24-well XF24 cell culture microplate (Seahorse Bioscience) at a density of
10,000 cells per well in 200 ml DMEM supplemented with 10% fetal bovine
serum (FBS). Cells were differentiated. The rate of oxygen consumed by the
cells as an indicator of mitochondrial respiration was measured using XF cell
mito stress test kit (Seahorse Bioscience), as per the manufacturer’s instruc-
tions. Three basal OCR measurements were performed using the Seahorse
analyzer, andmeasurements were repeated following the injection of oligomy-
cin, FCCP, and rotenone/antimycin A. Basal ECAR was determined from data
collected at basal measurement points.
Measurement of Endogenous Respiration Using Oxygraph 2K
Isolated mitochondria and tissues were used for oxygraphic measurements
(Oxygraph 2K; Oroboros Instruments) according to the manufacturer’s
protocol. The rate of oxygen consumed was recorded. Respiration rates
were normalized to total protein content.
Mitochondrial Isolation
Mitochondria were isolated from 3T3-L1 adipocytes and tissues using Mito-
chondria Isolation Kit according to the manufacturer’s protocol (Abcam).538 Cell Reports 17, 527–540, October 4, 2016Metabolic Expenditure Measurements
For basal metabolic expenditure measurements, mice were placed in an Oxy-
max metabolic Chamber (Columbus Instruments), and oxygen consumption
(VO2) and carbon dioxide expiration (VCO2) weremeasured using an open-cir-
cuit volumetric method of gas analysis (Desai et al., 1997). RERwas calculated
as VCO2/VO2. The rate of basal metabolic expenditure (BME) was calculated
using the subjects VO2 * calorific value (CV), which is the relationship between
heat and the volume of consumed oxygen. CVs are derived from historical
empirical data. BME was then normalized to whole-body weight (kg). Analysis
of the oxidation of carbohydrates and fats was calculated as previously
published.
Body Temperature and Cold Exposure
Body temperatures were assessed in 4-month-old mice using a RET-3 rectal
probe for mice (Physitemp). For the cold-exposure experiment, mice were
housed individually and transferred to a cold room with an ambient tempera-
ture of 4C. Temperature was measured every 30 min for 4 hr or until mouse
core body temperature dropped below 25C.
Triglyceride Quantification
Frozen liver tissue (50mg) was homogenized and total lipids were extracted by
the Folch method. Lipids were dried and reconstituted by brief sonication in
0.1% Triton X-100. TG content was quantified by using enzymatic assays
(Wako Pure Chemicals Industries).
Animal Exercise Protocol
Mice were exercised on a treadmill equipped for simultaneous measurement
of O2 consumption (VO2) and CO2 production (VCO2) (Columbus Instru-
ments), and distance run, total work, and RER were determined using estab-
lished protocols (Desai et al., 1997). Exercise capacity was assessed using a
protocol that incrementally increased the degree of elevation of the treadmill
by 2 and the speed by 2m/min every 3min. Micewere exercised until exhaus-
tion while monitoring VO2/CO2. Mice were not forced to exercise after
exhaustion.
Echocardiographic Assessment of Cardiac Function
Resting in vivo heart function was evaluated by echocardiography at 14–
15 weeks. Mice were anesthetized with isoflurane (2% inhalation). 2D clips
and M-mode images were obtained in the short-axis view from the mid-left
ventricle (mid-LV) at the tips of the papillary muscles with a Sonos 5500 echo-
cardiograph (Philips). Details are given in the Supplemental Experimental
Procedures.
Non-targeted Metabolomic and Lipidomic Experiments by Liquid
Chromatography-Mass Spectrometry
Metabolites were extracted frommouse plasma as described previously (Con-
trepois et al., 2015), and lipids were extracted using the Folch method with
some modifications. Pathway analysis was performed using the metabolites
with a Human Metabolome Database (HMDB) accession number in the web
tool Metaboanalyst (Xia et al., 2015). Details are given in the Supplemental
Experimental Procedures.
Generation of B6 3 BTBR Cross F2 Mice and Genotyping and Gene
Expression Data
Construction of the diabetes-segregating F2 cohort has been described pre-
viously (Tian et al., 2015; Tu et al., 2012). Details are given in the Supplemental
Experimental Procedures.
Analysis of Nat1-Correlated Gene Sets
GO and KEGG pathway enrichment analyses were performed using the DAVID
bioinformatic database at the NIH (https://david.ncifcrf.gov/). The 500 most
correlated genes to Nat1 (both positive and negative correlates) were identified
from500 adipose samples from the F2mice described above. The correlated
gene sets were uploaded to DAVID, resulting in the GO and KEGG enrichments
presented in Table S1. Mitochondrial genes were identified from the mouse
MitoCarta database at the Broad Institute (http://www.broadinstitute.org/files/
shared/metabolism/mitocarta/mouse.mitocarta.2.0.html). The mitochondrial
genes showing the strongest positive correlation to the adipose expression of
Nat1 are given in Table S1.
Statistical Analyses
Statistical analyses of the experiments were performed with GraphPad Prism
5.0. Two-tailed unpaired Student’s t test and ANOVA were applied to deter-
mine statistical significance (*p% 0.05, **p% 0.01, and ***p% 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.09.005.
AUTHOR CONTRIBUTIONS
I.C. contributed to basic science experiments in vitro and in vivo and writing
the manuscript. M.C. contributed to the mitochondrial experiments, helped
write sections of the manuscript, and provided critical comments. K.C.
contributed to the generation and analysis of metabolomics and lipidomics
data, helped write sections of themanuscript, and provided critical comments.
M.P.K. contributed to co-expression gene networks analysis, helped write
sections of the manuscript, and provided critical comments. I.C.-O., G.F.,
A.J.W., and M.F. contributed to basic science experiments. J.S. contributed
to basic science experiments in vivo. M.S., G.R., and T.Q. contributed to study
design, discussion, and manuscript preparation. A.D.A. contributed to co-
expression gene networks analysis and provided helpful comments and crit-
ical review of manuscript. D.B. contributed to the mitochondrial experiments
in vitro and in vivo and also provided critical comments on the manuscript.
J.W.K. conceived the work, contributed to the overall design, and helped write
the manuscript.
ACKNOWLEDGMENTS
J.W.K. was supported by an American Heart Association Fellow-to-Faculty
Transition Award (10FTF3360005) and by NIH grant U01HL107388. T.Q. was
supported by NIH grants (U01HL107388, HL109512, and R21HL120757) and
a grant from the LeDucq Foundation. M.C. was supported by NIH K99 award
HL12947401A1. K.C. was supported by NIH grant 3U54DK10255603S1.
I.C.-O. was supported by NIH grant U01HL107388. D.B. was supported by
NIH grant HL061535. The authors thank Erik Ingelsson and Mark Walker for
helpful comments.
Received: January 25, 2016
Revised: July 28, 2016
Accepted: August 31, 2016
Published: October 4, 2016
REFERENCES
Bogacka, I., Ukropcova, B., McNeil, M., Gimble, J.M., and Smith, S.R. (2005a).
Structural and functional consequences of mitochondrial biogenesis in human
adipocytes in vitro. J. Clin. Endocrinol. Metab. 90, 6650–6656.
Bogacka, I., Xie, H., Bray, G.A., and Smith, S.R. (2005b). Pioglitazone induces
mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Dia-
betes 54, 1392–1399.
Cannon, B., and Nedergaard, J. (2011). Nonshivering thermogenesis and its
adequate measurement in metabolic studies. J. Exp. Biol. 214, 242–253.
Chennamsetty, I., Claudel, T., Kostner, K.M., Baghdasaryan, A., Kratky, D.,
Levak-Frank, S., Frank, S., Gonzalez, F.J., Trauner, M., and Kostner, G.M.
(2011). Farnesoid X receptor represses hepatic human APOA gene expres-
sion. J. Clin. Invest. 121, 3724–3734.
Choo, H.J., Kim, J.H., Kwon, O.B., Lee, C.S., Mun, J.Y., Han, S.S., Yoon, Y.S.,
Yoon, G., Choi, K.M., and Ko, Y.G. (2006). Mitochondria are impaired in the
adipocytes of type 2 diabetic mice. Diabetologia 49, 784–791.Church, T.S., Cheng, Y.J., Earnest, C.P., Barlow, C.E., Gibbons, L.W., Priest,
E.L., and Blair, S.N. (2004). Exercise capacity and body composition as predic-
tors of mortality among men with diabetes. Diabetes Care 27, 83–88.
Contrepois, K., Jiang, L., and Snyder, M. (2015). Optimized analytical proced-
ures for the untargeted metabolomic profiling of human urine and plasma by
combining hydrophilic interaction (HILIC) and reverse-phase liquid chroma-
tography (RPLC)-mass spectrometry. Mol. Cell. Proteomics 14, 1684–1695.
De Pauw, A., Tejerina, S., Raes, M., Keijer, J., and Arnould, T. (2009). Mito-
chondrial (dys)function in adipocyte (de)differentiation and systemic metabolic
alterations. Am. J. Pathol. 175, 927–939.
Desai, K.H., Sato, R., Schauble, E., Barsh, G.S., Kobilka, B.K., and Bernstein,
D. (1997). Cardiovascular indexes in the mouse at rest and with exercise: new
tools to study models of cardiac disease. Am. J. Physiol. 272, H1053–H1061.
Disatnik, M.H., Ferreira, J.C.B., Campos, J.C., Gomes, K.S., Dourado, P.M.M.,
Qi, X., and Mochly-Rosen, D. (2013). Acute inhibition of excessive mitochon-
drial fission after myocardial infarction prevents long-term cardiac dysfunc-
tion. J. Am. Heart Assoc. 2, e000461.
Dorn, G.W., 2nd. (2015). Mitochondrial dynamism and heart disease: changing
shape and shaping change. EMBO Mol. Med. 7, 865–877.
Enerba¨ck, S., Jacobsson, A., Simpson, E.M., Guerra, C., Yamashita, H.,
Harper, M.-E., and Kozak, L.P. (1997). Mice lacking mitochondrial uncoupling
protein are cold-sensitive but not obese. Nature 387, 90–94.
Facchini, F.S., Hua, N., Abbasi, F., and Reaven, G.M. (2001). Insulin resistance
as a predictor of age-related diseases. J. Clin. Endocrinol. Metab. 86, 3574–
3578.
Fang, Z.Y., Sharman, J., Prins, J.B., andMarwick, T.H. (2005). Determinants of
exercise capacity in patients with type 2 diabetes. Diabetes Care 28, 1643–
1648.
Feldmann, H.M., Golozoubova, V., Cannon, B., and Nedergaard, J. (2009).
UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in
mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 9,
203–209.
Ferrannini, E., Natali, A., Camastra, S., Nannipieri, M., Mari, A., Adam, K.-P.,
Milburn, M.V., Kastenm€uller, G., Adamski, J., Tuomi, T., et al. (2013). Early
metabolic markers of the development of dysglycemia and type 2 diabetes
and their physiological significance. Diabetes 62, 1730–1737.
Floegel, A., Stefan, N., Yu, Z., M€uhlenbruch, K., Drogan, D., Joost, H.-G.,
Fritsche, A., Ha¨ring, H.-U., Hrabe de Angelis, M., Peters, A., et al. (2013). Iden-
tification of serum metabolites associated with risk of type 2 diabetes using a
targeted metabolomic approach. Diabetes 62, 639–648.
Frayn, K.N. (2001). Adipose tissue and the insulin resistance syndrome. Proc.
Nutr. Soc. 60, 375–380.
Gall, W.E., Beebe, K., Lawton, K.A., Adam, K.-P., Mitchell, M.W., Nakhle, P.J.,
Ryals, J.A., Milburn, M.V., Nannipieri, M., Camastra, S., et al.; RISC Study
Group (2010). a-hydroxybutyrate is an early biomarker of insulin resistance
and glucose intolerance in a nondiabetic population. PLoS ONE 5, e10883.
Giesbertz, P., Padberg, I., Rein, D., Ecker, J., Ho¨fle, A.S., Spanier, B., and
Daniel, H. (2015). Metabolite profiling in plasma and tissues of ob/ob and
db/db mice identifies novel markers of obesity and type 2 diabetes. Diabeto-
logia 58, 2133–2143.
Handschin, C., Choi, C.S., Chin, S., Kim, S., Kawamori, D., Kurpad, A.J.,
Neubauer, N., Hu, J., Mootha, V.K., Kim, Y.-B., et al. (2007). Abnormal glucose
homeostasis in skeletal muscle-specific PGC-1a knockout mice reveals skel-
etal muscle-pancreatic b cell crosstalk. J. Clin. Invest. 117, 3463–3474.
Johnson, A.M.F., and Olefsky, J.M. (2013). The origins and drivers of insulin
resistance. Cell 152, 673–684.
Kelley, D.E., He, J., Menshikova, E.V., and Ritov, V.B. (2002). Dysfunction
of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51,
2944–2950.
Kim, J.-Y., Hickner, R.C., Cortright, R.L., Dohm, G.L., and Houmard, J.A.
(2000). Lipid oxidation is reduced in obese human skeletal muscle. Am. J.
Physiol. Endocrinol. Metab. 279, E1039–E1044.Cell Reports 17, 527–540, October 4, 2016 539
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M.E., Hofmann,
S.M., Schraw, T., Durand, J.L., Li, H., Li, G., et al. (2007). Obesity-associated
improvements in metabolic profile through expansion of adipose tissue.
J. Clin. Invest. 117, 2621–2637.
Kim, H.-J., Kim, J.H., Noh, S., Hur, H.J., Sung, M.J., Hwang, J.-T., Park, J.H.,
Yang, H.J., Kim, M.-S., Kwon, D.Y., and Yoon, S.H. (2011). Metabolomic anal-
ysis of livers and serum from high-fat diet induced obese mice. J. Proteome
Res. 10, 722–731.
Kim, M.J., Yang, H.J., Kim, J.H., Ahn, C.-W., Lee, J.H., Kim, K.S., and Kwon,
D.Y. (2013). Obesity-related metabolomic analysis of human subjects in black
soybean peptide intervention study by ultraperformance liquid chromatog-
raphy and quadrupole-time-of-flight mass spectrometry. J. Obes. 2013,
874981.
Kleiner, S., Mepani, R.J., Laznik, D., Ye, L., Jurczak, M.J., Jornayvaz, F.R.,
Estall, J.L., Chatterjee Bhowmick, D., Shulman, G.I., and Spiegelman, B.M.
(2012). Development of insulin resistance in mice lacking PGC-1a in adipose
tissues. Proc. Natl. Acad. Sci. USA 109, 9635–9640.
Knowles, J.W., Xie, W., Zhang, Z., Chennamsetty, I., Assimes, T.L., Paananen,
J., Hansson, O., Pankow, J., Goodarzi, M.O., Carcamo-Orive, I., et al.; RISC
(Relationship between Insulin Sensitivity and Cardiovascular Disease) Con-
sortium; EUGENE2 (European Network on Functional Genomics of Type 2Dia-
betes) Study; GUARDIAN (Genetics UndeRlying DIAbetes in HispaNics) Con-
sortium; SAPPHIRe (Stanford Asian and Pacific Program for Hypertension and
Insulin Resistance) Study (2015). Identification and validation of N-acetyltrans-
ferase 2 as an insulin sensitivity gene. J. Clin. Invest. 125, 1739–1751.
Lee, J., Ellis, J.M., and Wolfgang, M.J. (2015). Adipose fatty acid oxidation is
required for thermogenesis and potentiates oxidative stress-induced inflam-
mation. Cell Rep. 10, 266–279.
Matthias, A., Ohlson, K.B.E., Fredriksson, J.M., Jacobsson, A., Nedergaard,
J., and Cannon, B. (2000). Thermogenic responses in brown fat cells are fully
UCP1-dependent. UCP2 or UCP3 do not substitute for UCP1 in adrenergically
or fatty scid-induced thermogenesis. J. Biol. Chem. 275, 25073–25081.
Morino, K., Petersen, K.F., and Shulman, G.I. (2006). Molecular mechanisms
of insulin resistance in humans and their potential links with mitochondrial
dysfunction. Diabetes 55 (Suppl 2), S9–S15.
Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F.,
Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., et al. (2009). A branched-
chain amino acid-related metabolic signature that differentiates obese and
lean humans and contributes to insulin resistance. Cell Metab. 9, 311–326.
Noland, R.C., Koves, T.R., Seiler, S.E., Lum, H., Lust, R.M., Ilkayeva, O., Ste-
vens, R.D., Hegardt, F.G., and Muoio, D.M. (2009). Carnitine insufficiency
caused by aging and overnutrition compromises mitochondrial performance
and metabolic control. J. Biol. Chem. 284, 22840–22852.
Patti, M.-E., and Corvera, S. (2010). The role of mitochondria in the pathogen-
esis of type 2 diabetes. Endocr. Rev. 31, 364–395.540 Cell Reports 17, 527–540, October 4, 2016Petersen, K.F., Dufour, S., Befroy, D., Garcia, R., and Shulman, G.I. (2004).
Impaired mitochondrial activity in the insulin-resistant offspring of patients
with type 2 diabetes. N. Engl. J. Med. 350, 664–671.
Reaven, G.M. (1988). Banting lecture 1988. Role of insulin resistance in human
disease. Diabetes 37, 1595–1607.
Ricquier, D., and Bouillaud, F. (2000). The uncoupling protein homologues:
UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem. J. 345, 161–179.
Roberts, L.D., Koulman, A., and Griffin, J.L. (2014). Towards metabolic bio-
markers of insulin resistance and type 2 diabetes: progress from the metabo-
lome. Lancet Diabetes Endocrinol. 2, 65–75.
Schooneman, M.G., Vaz, F.M., Houten, S.M., and Soeters, M.R. (2013). Acyl-
carnitines: reflecting or inflicting insulin resistance? Diabetes 62, 1–8.
Schrauwen, P., and Hesselink, M.K.C. (2004). Oxidative capacity, lipotoxicity,
and mitochondrial damage in type 2 diabetes. Diabetes 53, 1412–1417.
Sivitz, W.I., and Yorek, M.A. (2010). Mitochondrial dysfunction in diabetes:
from molecular mechanisms to functional significance and therapeutic oppor-
tunities. Antioxid. Redox Signal. 12, 537–577.
Tian, J., Keller, M.P., Oler, A.T., Rabaglia, M.E., Schueler, K.L., Stapleton, D.S.,
Broman, A.T., Zhao, W., Kendziorski, C., Yandell, B.S., et al. (2015). Identifica-
tion of the bile acid transporter Slco1a6 as a candidate gene that broadly af-
fects gene expression in mouse pancreatic islets. Genetics 201, 1253–1262.
Tu, Z., Keller, M.P., Zhang, C., Rabaglia, M.E., Greenawalt, D.M., Yang, X.,
Wang, I.M., Dai, H., Bruss, M.D., Lum, P.Y., et al. (2012). Integrative analysis
of a cross-loci regulation network identifies App as a gene regulating insulin
secretion from pancreatic islets. PLoS Genet. 8, e1003107.
Vianna, C.R., Huntgeburth, M., Coppari, R., Choi, C.S., Lin, J., Krauss, S., Bar-
batelli, G., Tzameli, I., Kim, Y.-B., Cinti, S., et al. (2006). Hypomorphic mutation
of PGC-1b causes mitochondrial dysfunction and liver insulin resistance. Cell
Metab. 4, 453–464.
Wang, Y., Rimm, E.B., Stampfer, M.J., Willett, W.C., and Hu, F.B. (2005). Com-
parison of abdominal adiposity and overall obesity in predicting risk of type 2
diabetes among men. Am. J. Clin. Nutr. 81, 555–563.
Wang-Sattler, R., Yu, Z., Herder, C., Messias, A.C., Floegel, A., He, Y., Heim,
K., Campillos, M., Holzapfel, C., Thorand, B., et al. (2012). Novel biomarkers for
pre-diabetes identified by metabolomics. Mol. Syst. Biol. 8, 615.
Weyer, C., Foley, J.E., Bogardus, C., Tataranni, P.A., and Pratley, R.E. (2000).
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself,
predicts type II diabetes independent of insulin resistance. Diabetologia 43,
1498–1506.
Wolf, G. (2009). Brown adipose tissue: the molecular mechanism of its forma-
tion. Nutr. Rev. 67, 167–171.
Xia, J., Sinelnikov, I.V., Han, B., and Wishart, D.S. (2015). MetaboAnalyst 3.0–
making metabolomics more meaningful. Nucleic Acids Res. 43, W251–257.
Yip, J., Facchini, F.S., and Reaven, G.M. (1998). Resistance to insulin-medi-
ated glucose disposal as a predictor of cardiovascular disease. J. Clin. Endo-
crinol. Metab. 83, 2773–2776.
